Search results
Drug names: How companies and regulators come up with hundreds of new names every year
Quartz· 12 hours agoEverything you need to know about the art and science of drug naming in five minutes or less,...
Here are four reasons Medicare drug-price "negotiation" in NJ isn't truly a negotiation.
Gannett via AOL· 7 days agoFour reasons Medicare drug-price "negotiation" isn't truly a negotiation. For 2024, New Jersey...
Medicare Advantage cuts coming this year, retirement specialist warns
Newsweek· 2 days agoMedicare Advantage cuts are likely to come during the next year. Bob Carlson, an attorney and...
Kirsten Axelsen: Affordable access to weight loss drugs needed (Opinion)
The Charleston Gazette· 4 hours agoSen. Bernie Sanders, I-Vt., is getting a piece of the attention being paid to weight loss drugs. Unsurprisingly, these medicines have gotten a lot of notice; losing weight and keeping it off ...
Here are four reasons Medicare drug-price 'negotiation' in NJ isn't truly a negotiation.
App.com | Asbury Park Press via Yahoo News· 7 days agodrug benefit. Dubbing it a negotiation only obscures the reality of a process in which the...
Weight Loss Drugs and Medicare: What You Need to Know
TheStreet.com· 7 days agoMore weight loss drugs have been approved for coverage by Medicare, but what are the challenges potential users face? Medicare has recently approved coverage of GLP-1 drugs such as Wegovy to address hypertension.
Fact check: Trump falsely claims Biden didn’t lower Americans’ insulin costs | CNN Politics
CNN.com· 6 days agoPresident Joe Biden is campaigning on his success in getting seniors with diabetes a $35-per-month...
Fact check: Trump falsely claims Biden didn’t lower Americans’ insulin costs
CNN via Yahoo News· 6 days agoTrump’s policy didn’t Biden’s policy, which took effect in 2023, requires every prescription drug ...
Is the Inflation Reduction Act failing Oklahoma’s senior citizens? | Opinion
The Oklahoman via Yahoo News· 21 hours agoThere is no better example than the skyrocketing cost of prescription drug premiums for Medicare...
US Drug Negotiations Plan Shifts Focus for Rare Disease Programs
Bloomberg Law· 3 days agoThe rare disease community is pushing for changes in the Inflation Reduction Act’s drug price-setting scheme as it leads more drugmakers and investors to reconsider development ...